CA2029704A1 - Utilisation de derives de pyrimidone et de leurs analogues pour le traitement de l'asthme et de certaines dermatopathies - Google Patents

Utilisation de derives de pyrimidone et de leurs analogues pour le traitement de l'asthme et de certaines dermatopathies

Info

Publication number
CA2029704A1
CA2029704A1 CA2029704A CA2029704A CA2029704A1 CA 2029704 A1 CA2029704 A1 CA 2029704A1 CA 2029704 A CA2029704 A CA 2029704A CA 2029704 A CA2029704 A CA 2029704A CA 2029704 A1 CA2029704 A1 CA 2029704A1
Authority
CA
Canada
Prior art keywords
asthma
treatment
skin disorders
analogs
certain skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2029704A
Other languages
English (en)
Other versions
CA2029704C (fr
Inventor
John B. Cheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CA2029704A1 publication Critical patent/CA2029704A1/fr
Application granted granted Critical
Publication of CA2029704C publication Critical patent/CA2029704C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002029704A 1989-11-13 1990-11-09 Utilisation de derives de pyrimidone et de leurs analogues pour le traitement de l'asthme et de certaines dermatopathies Expired - Fee Related CA2029704C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USPCT/US89/05221 1989-11-13
PCT/US1989/005221 WO1991007177A1 (fr) 1989-11-13 1989-11-13 Derives de pyrimidone et analogues pour le traitement de l'asthme et de certaines maladies de la peau

Publications (2)

Publication Number Publication Date
CA2029704A1 true CA2029704A1 (fr) 1991-05-14
CA2029704C CA2029704C (fr) 1995-02-07

Family

ID=22215372

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002029704A Expired - Fee Related CA2029704C (fr) 1989-11-13 1990-11-09 Utilisation de derives de pyrimidone et de leurs analogues pour le traitement de l'asthme et de certaines dermatopathies

Country Status (17)

Country Link
US (1) US5342842A (fr)
EP (1) EP0428313B1 (fr)
JP (2) JPH0662412B2 (fr)
KR (1) KR930001832B1 (fr)
AT (1) ATE101040T1 (fr)
AU (1) AU627631B2 (fr)
CA (1) CA2029704C (fr)
DE (1) DE69006452T2 (fr)
DK (1) DK0428313T3 (fr)
HU (1) HU212311B (fr)
IE (1) IE63472B1 (fr)
IL (1) IL96260A (fr)
MY (1) MY111474A (fr)
NZ (1) NZ236038A (fr)
PT (1) PT95854B (fr)
WO (2) WO1991007177A1 (fr)
ZA (1) ZA909043B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
CA2150812C (fr) * 1992-12-02 2002-12-24 Allen J. Duplantier Diethers de catechol utilises comme inhibiteurs selectifs de la phosphodiesterase de type iv
US5814651A (en) * 1992-12-02 1998-09-29 Pfizer Inc. Catechol diethers as selective PDEIV inhibitors
US5482944A (en) * 1993-07-13 1996-01-09 Pfizer Inc. Pyrimidones and imidazolinones for treatment of shock
US5502072A (en) * 1993-11-26 1996-03-26 Pfizer Inc. Substituted oxindoles
ES2139754T3 (es) * 1993-11-26 2000-02-16 Pfizer 3-fenil-2-isoxazolinas como agentes antiinflamatorios.
WO1995024192A1 (fr) * 1994-03-09 1995-09-14 Pfizer Inc. Composes d'isoxazoline agissant comme inhibiteurs de 5-lipoxygenase
CA2185019C (fr) * 1994-03-09 2000-08-08 Pfizer Limited Isoxazolines, inhibiteurs de la liberation du fnt
US5563143A (en) * 1994-09-21 1996-10-08 Pfizer Inc. Catechol diether compounds as inhibitors of TNF release
JP4373497B2 (ja) 1996-06-19 2009-11-25 ローン−プーラン・ロレ・リミテツド 置換されたアザビシクロ化合物、ならびにｔｎｆおよびサイクリックａｍｐホスホジエステラーゼ産生の阻害剤としてのそれらの使用
CA2264685C (fr) 1996-08-27 2002-10-15 Kyoji Noda Derives du 2-phenylmorpholin-5-one et composition pharmaceutique les comprenant
EP2258689A1 (fr) * 2000-03-16 2010-12-08 Biolipox AB Inhibiteurs benzyles de PDE4

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2401446A1 (de) * 1973-01-16 1974-07-25 Voorhees Pharmazeutische zubereitungen zur linderung von hautproliferationserkrankungen
SU888821A3 (ru) * 1976-12-03 1981-12-07 Шеринг Аг (Инофирма) Способ получени 5-(замещенный фенил)-оксазолидинонов или их серусодержащих аналогов
DE3315797A1 (de) * 1983-04-30 1984-10-31 Beiersdorf Ag, 2000 Hamburg Substituierte phenyl-2-(1h)-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
GB8416140D0 (en) * 1984-06-25 1984-08-01 Fujisawa Pharmaceutical Co Pyrimidinone derivatives
WO1987006576A1 (fr) * 1986-04-29 1987-11-05 Pfizer Inc. ANTIDEPRESSEUR INHIBITEUR DE PHOSPHODIESTERASE DE MPA-c INDEPENDANTE DU CALCIUM

Also Published As

Publication number Publication date
IE904058A1 (en) 1991-05-22
IL96260A (en) 1995-11-27
EP0428313B1 (fr) 1994-02-02
AU6653690A (en) 1991-08-01
JP2514163B2 (ja) 1996-07-10
HU9201575D0 (en) 1993-04-28
DE69006452D1 (de) 1994-03-17
PT95854A (pt) 1991-09-13
IE63472B1 (en) 1995-04-19
AU627631B2 (en) 1992-08-27
WO1991007178A1 (fr) 1991-05-30
PT95854B (pt) 1997-11-28
WO1991007177A1 (fr) 1991-05-30
DK0428313T3 (da) 1994-03-07
HUT70052A (en) 1995-09-28
EP0428313A2 (fr) 1991-05-22
JPH0748255A (ja) 1995-02-21
HU212311B (en) 1996-05-28
MY111474A (en) 2000-06-30
US5342842A (en) 1994-08-30
JPH03209322A (ja) 1991-09-12
IL96260A0 (en) 1991-08-16
EP0428313A3 (en) 1991-11-06
JPH0662412B2 (ja) 1994-08-17
NZ236038A (en) 1997-03-24
KR910009259A (ko) 1991-06-28
KR930001832B1 (ko) 1993-03-15
CA2029704C (fr) 1995-02-07
DE69006452T2 (de) 1994-05-11
ATE101040T1 (de) 1994-02-15
ZA909043B (en) 1992-06-24

Similar Documents

Publication Publication Date Title
CA2004747A1 (fr) Composes pharmaceutiques ayant une action sur le snc
CA2067221A1 (fr) Derive pyrimidine a cycles condenses, procede pour sa preparation et preparation pharmaceutique en contenant comme ingredient actif
CA2008108A1 (fr) Agents bis-aza-bicycliques anxiolytiques
CA2029704A1 (fr) Utilisation de derives de pyrimidone et de leurs analogues pour le traitement de l'asthme et de certaines dermatopathies
AU518470B2 (en) 2-(2-alkoxyethyl)-2:-hydroxy-6,7-benzomorphanes
MY117090A (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
CA2093403A1 (fr) Agent de traitement de la maladie de parkinson
AU7554987A (en) Solutions of oxazaphosphorins having improved stability and process for the preparation thereof
JPS6422813A (en) Antiphlegmonic slimming cosmetics containing 1-hydroxyalkylxanthin
EP0205334A3 (fr) Dérivés de benzazépine
NZ505103A (en) Phenylaminoalkylcarboxylic acid derivatives useful as beta 3 adrenoceptor stimulants
CA2126518A1 (fr) Utilisation de phenylalkylamines
EP0186023A3 (fr) Dérivés d'acides biliaires, procédé pour leur préparation et compositions pharmaceutiques les contenant
EP0348170A3 (fr) Dérivés antiviraux de pyrimidine
EP0331078A3 (fr) Procédé de préparation de dérivés optiquement actifs de l'acide 4-oxo-benzopyranne-2-carboxylique et leurs intermédiaires
CA2152191A1 (fr) Agent therapeutique pour le glaucome et agent hypotenseur oculaire
RU92004529A (ru) Производные 2-азабицикло /2,2,1/гепт-5-ен-2-уксусной кислоты
SG58291G (en) Anticonvulsant agents
CA2135541A1 (fr) Methode pour la preparation de 5-chloroimidazole-4-carbaldehydes substitues en 2
AU687023B2 (en) Use of idazoxan and derivatives thereof in preparing a drug for treating parkinson's disease and its development
TR199900013T2 (xx) Yeni bile�ikler.
EP0372941A3 (fr) 5-Hydroxy-2-furanones anti-inflammatoires
CA2164152A1 (fr) Composes de la classe des secomacrolides et des secoazalides; methode de preparation
DE3561512D1 (de) Diphenylmethylimine derivatives
CA2241933A1 (fr) Procede de preparation de derives d'alcoxypyrazine

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed